Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
Posted 01 June 2012 | By Louise Zornoza,
China's State Food and Drug Administration (SFDA) has released a report detailing the adverse event reports it received during 2011. The report notes events involving anti-infective medicines accounted for the higher number of reports, including cephalosporins (34.8%), penicillin (14%) and quinolones (12.2%).
New and serious adverse drug reactions accounted for 17.1% of the total number of reports. Medical institutions were the primary source for such reports, accounting for about 83% of all reported events.
2011 adverse reactions report
More Breaking News from RegLink
Tags: Anti-Infectives, Adverse Events, Report, Reporting, 2011
Regulatory Focus newsletters
All the biggest regulatory news and happenings.